patients with excessive gingival display Excessive gingival display Botulinum toxin
Conditions
Interventions
the first group will receive 2.5 IU. At one site per side (a total of two sites) The solution will be injected 3 mm lateral to the alar-
facial groove at the level of the nostril opening at the insertion of the levator labii superioris alaeque nasi muscle,
2.5IU for each side,The second group will receive botulinum toxin injection at 2 sites 5IU per side (a total of four sites) into: (1) levator labii superioris alaeque nasi with the levator labii super
the junction/approximation of the levator labii superioris and the zygomaticus minor. The dose given to each patient in this study is based on previously published information that cited a range of 2
Active Comparator Drug,Experimental Drug
injection at single site per side,injection at 2 sites per side
Sponsors
None
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: healthy patients with excessive gingival display due to muscular hyperfunction which will be determined by the degree of lip mobility
Exclusion criteria
Exclusion criteria: Patients with gingival display due to short clinical crowns or long maxilla, pregnant patients, or patients who are breastfeeding, as well as patients with neuromuscular disorders.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Amount of improvement 2 and 16 weeks The distance between the lower margin of the upper lip and the incisal edge | — |
Secondary
| Measure | Time frame |
|---|---|
| Degree of satisfaction 2 and 16 weeks 5-point aesthetic scale | — |
Countries
Iraq
Contacts
Public ContactSalwan Bede
College of Dentistry, University of Baghdad
Outcome results
None listed